Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03172416 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis(PIPAC) | unknown | Phase 1 | 21 | National University Hospital, SingaporeOTHER | 2 | May 29, 2024 | clinicaltrials |
| NCT03714490 | MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer(SUNRISE) | unknown | Phase 2 | 200 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences |
| 1 |
| May 29, 2024 |
| clinicaltrials |
| NCT03921671 | Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)(RELEVENT) | unknown | Phase 2 | 60 | Claudia ProtoOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT04656639 | Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer | unknown | — | 580 | Seoul National University HospitalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05304156 | Single-cell Dynamic Profiling in Adults With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. A THEMA Study"(DYNHAEMICS) | unknown | — | 200 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05307757 | Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer | unknown | — | 1,098 | Seoul National University HospitalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05395910 | Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis | unknown | Phase 1 | 36 | National University Hospital, SingaporeOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05493800 | Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT(Capella) | unknown | Phase 2 | 60 | MitoImmune TherapeuticsINDUSTRY | 1 | May 29, 2024 | clinicaltrials |
| NCT06431724 | A Review of Cervical Cancer Screening Practices in Women Age >65 | unknown | — | 300 | Sarasota Memorial Health Care SystemOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06432205 | The Effect of MDT Plus SDM on Survival Benefit of Advanced Gastric Cancer | unknown | — | 121 | Peking UniversityOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06432426 | Virtual Exercise on Elderly Breast Cancer Survivors | unknown | N/A | 60 | Pontificia Universidad Catolica de ChileOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06432556 | Study of Cellular Heterogeneity in Patients With Mastocytosis(MastCellHet) | unknown | N/A | 26 | University Hospital, ToulouseOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06433063 | Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment(LuMISO) | unknown | N/A | 30 | Cigdem SoydalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06433362 | CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma | unknown | Phase 2 | 115 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT01305499 | A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML) | unknown | Phase 2 | 52 | Hetty CarrawayOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT03275493 | CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia | unknown | Phase 1 / Phase 2 | 40 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdINDUSTRY | 1 | May 28, 2024 | clinicaltrials |
| NCT05547594 | Prehabilitation in Patients With Cancer and Type 2 Diabetes | unknown | N/A | 60 | University of GreenwichOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT05605197 | U87 CART in Treatment of Advanced Solid Tumor | unknown | Phase 1 | 12 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdINDUSTRY | 1 | May 28, 2024 | clinicaltrials |
| NCT06429865 | Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma | unknown | N/A | 1,000 | Changhai HospitalOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT06429878 | The Long Term Effect of MRI Before Radical Prostatectomy. | unknown | N/A | 438 | Oslo University HospitalOTHER | 0 | May 28, 2024 | clinicaltrials |
| NCT06431529 | A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors(Neoantigen-T) | unknown | Early Phase 1 | 6 | JIANG LONGWEIOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT03705546 | The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer | unknown | — | 1,050 | Samsung Medical CenterOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04000906 | PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis(Nab-PIPAC) | unknown | Phase 1 | 18 | University Hospital, GenevaOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04945928 | Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC | unknown | N/A | 30 | Ruijin HospitalOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT05799248 | Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management | unknown | Phase 3 | 113 | MidLantic UrologyOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT04571762 | Adaptive MR-guided SBRT for Localized Prostate Cancer | unknown | N/A | 12 | University of ZurichOTHER | 0 | May 23, 2024 | clinicaltrials |
| NCT04799548 | A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma | unknown | Phase 2 | 71 | Shanghai Zhongshan HospitalOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT05412849 | Radiation Field, Dose and Fractionation Related to Mandibular Complications | unknown | — | 120 | Lund University HospitalOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT05878028 | L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC | unknown | Phase 2 | 33 | Quanli GaoOTHER_GOV | 1 | May 23, 2024 | clinicaltrials |
| NCT06227156 | Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer | unknown | Phase 2 | 40 | RemeGen Co., Ltd.INDUSTRY | 1 | May 23, 2024 | clinicaltrials |
| NCT06424379 | BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.(BCL6-RINHL) | unknown | — | 135 | Hospices Civils de LyonOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06427291 | Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients | unknown | Phase 1 | 20 | Fudan UniversityOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT03724500 | Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer | unknown | — | 65 | Chang Gung Memorial HospitalOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05386225 | Individualized Follow-Up for Head and Neck Cancer(INFLUENCE) | unknown | — | 210 | Radboud University Medical CenterOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05483712 | Brass Mesh Bolus in Rotational Post-Mastectomy Radiation Therapy | unknown | N/A | 20 | Nova Scotia Cancer CentreOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05622162 | Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7(MIP7) | unknown | Phase 3 | 106 | ITEL Telecomunicazioni SrlINDUSTRY | 1 | May 22, 2024 | clinicaltrials |
| NCT05984797 | Integrated Short-Term Palliative Rehabilitation in Incurable Cancer(INSPIRE) | unknown | N/A | 340 | King's College LondonOTHER | 5 | May 22, 2024 | clinicaltrials |
| NCT06417606 | Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 20 | Zhiyong HuangOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06424821 | Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC(LungCadX) | unknown | Phase 2 | 54 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06424873 | Dynamic Whole-body PET/CT Imaging in Clinical Oncology(Dynamic PET/CT) | unknown | N/A | 60 | Valentina GaribottoOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT06425315 | Management of Malnutrition in Oncogeriatrics | unknown | — | 120 | Hospices Civils de LyonOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT03992456 | Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer | unknown | Phase 2 | 12 | Academic and Community Cancer Research UnitedOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT04092673 | Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies(Zotatifin) | unknown | Phase 1 / Phase 2 | 30 | Effector TherapeuticsINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT04134000 | Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)(BladderGATE) | unknown | Phase 1 | 40 | Fundacion OncosurNETWORK | 1 | May 21, 2024 | clinicaltrials |
| NCT04418154 | Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients(NeoTENNIS) | unknown | Phase 2 | 70 | Fudan UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05490719 | A Phase II Study of CRT Combined With QL1706 in ESCC Patients | unknown | Phase 2 | 39 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05955105 | A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 200 | Innolake BiopharmINDUSTRY | 1 | May 21, 2024 | clinicaltrials |
| NCT05964101 | Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma(GALAXY-1) | unknown | Phase 2 | 25 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
Data updated 23 days agoSource updated May 29, 2024source: clinicaltrials